During the past decade, Clínica Universidad de Navarra conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 3 clinical trials were completed, i.e. on average, 3.7% percent of trials that started reached the finish line to date. In the past 5 years, 69 clinical trials started and 3 clinical trials were completed. i.e. 4.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clínica Universidad de Navarra" #1 sponsor was "Clinica Universidad de Navarra, Universidad de Navarra" with 5 trials, followed by "Grupo Español de Investigación en Cáncer de Ovario" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clínica Universidad de Navarra" #1 collaborator was "AKRN Scientific Consulting, S.L." with 2 trials as a collaborator, "Amgen" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Itreas" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Clínica Universidad de Navarra" are "Pulmonary Embolism" (5 trials), "Fallopian Tube Cancer" (4 trials), "Advanced Cancer" (3 trials), "Breast Cancer" (3 trials) and "Cervical Cancer" (3 trials). Many other conditions were trialed in "Clínica Universidad de Navarra" in a lesser frequency.

Most popular intervention types in "Clínica Universidad de Navarra" are "Drug" (70 trials), "Biological" (7 trials), "Device" (5 trials), "Other" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Pembrolizumab" (5 trials), "Atezolizumab" (4 trials), "Carboplatin" (4 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clínica Universidad de Navarra" are 71 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 60 active trials in "Clínica Universidad de Navarra". 2 are not yet recruiting, 33 are recruiting, 24 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in Clínica Universidad de Navarra, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clínica Universidad de Navarra, 20 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 4 trials that are defined as “Not Applicable".